You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,919,775


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,919,775
Title: Method for inhibiting expression of inducible nitric oxide synthase with tetracycline
Abstract:The invention is a method of inhibiting the production of nitric oxide (NO) in an in vivo, in vitro, or ex vivo biological system. The method employs a tetracycline compound to inhibit the production of NO and/or to inhibit the expression or activity of an inducible isoform of nitric oxide synthase (iNOS). Preferably, the tetracycline compound has inhibitory activity for metalloproteinases. Also it is preferred that the tetracycline compound is provided to the biological system in an amount which has little or no antibacterial activity in the system. Accordingly, preferred tetracycline compounds are tetracycline compounds which have be modified to reduce or eliminate their antimicrobial activity. The method can be used to treat medical conditions in mammals characterized by NO production mediated by iNOS, including, for example, inflammatory conditions.
Inventor(s): Amin; Ashok R. (Union, NJ), Abramson; Steven B. (Rye, NY), Golub; Lorne M. (Smithtown, NY), Ramamurthy; Nungavaram S. (Smithtown, NY), McNamara; Thomas F. (Port Jefferson, NY), Greenwald; Robert A. (Melville, NY), Trachtman; Howard (New Rochelle, NY)
Assignee: The Research Foundation of The State University of New York (Stony Brook, NY) Hospital For Joint Diseases (New York, NY)
Application Number:09/061,286
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

United States Patent 5,919,775: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 5,919,775, part of the "Amin Patents," is a significant intellectual property asset in the pharmaceutical industry, particularly in the context of acne rosacea treatment. This patent, along with others in the same family, has been involved in several legal disputes, highlighting its importance. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Background and Invention

The patent in question, U.S. Patent No. 5,919,775, is titled "Method for the treatment of acne rosacea" and was granted to Galderma Laboratories, L.P. The invention pertains to a method of treating acne rosacea using a specific formulation of doxycycline, a tetracycline antibiotic. This formulation is designed to minimize the antibiotic's antimicrobial activity while retaining its anti-inflammatory properties, which are beneficial for treating the condition[2].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the core aspects of the invention. These claims typically outline the method of treatment, the specific formulation of doxycycline, and the dosage regimen. For instance, Claim 1 might describe the method of treating acne rosacea by administering a pharmaceutical composition containing doxycycline in a specific concentration.

Dependent Claims

Dependent claims build upon the independent claims by adding additional limitations or features. These claims are crucial as they can provide further specificity and protection. For example, Claim 2 of U.S. Patent No. 5,919,775 might include an additional limitation such as "wherein the tetracycline compound has substantially no anti-microbial activity in said mammal system," which was a key point in the legal dispute involving Mylan Pharmaceuticals Inc.[2][5].

Legal Disputes and Validity

Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc.

This patent was part of a significant legal case where the validity of its claims was challenged. The lower court initially invalidated all asserted claims, including the dependent claims, due to prior art references. However, the Federal Circuit vacated the finding of invalidity for three dependent claims because the lower court did not address the additional limitation of "substantially no anti-microbial activity." This highlights the importance of carefully examining all claims, especially dependent ones, when assessing patent validity[2].

Patent Landscape

Related Patents

The "Amin Patents" include U.S. Patent Nos. 5,789,395 and 5,919,775, both of which are related to the treatment of acne rosacea using doxycycline. These patents, along with the "Ashley Patents" and the "Chang Patent," form a robust patent portfolio protecting Galderma's product Oracea®. Understanding the interconnections between these patents is essential for navigating the patent landscape in this field[2].

Global Patent Family

To fully understand the scope of protection, it is necessary to look at the global patent family. Tools like the Global Dossier provided by the USPTO allow users to see related applications filed at participating IP Offices, including the IP5 Offices. This helps in identifying the broader international protection and any potential gaps or opportunities[1].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

Using patent analytics tools, such as those provided by Schwegman, can help in understanding which patents and claims are actively protecting the intellectual property. A Claim Coverage Matrix categorizes patents by claims and scope concepts, making it easier to identify gaps in coverage and future design opportunities. This is particularly useful for companies with large patent portfolios, as it helps in managing and optimizing their intellectual property assets[3].

Interactive Claim Charts

Interactive claim charts generated by tools like ClaimScape® software can be reviewed by technical experts to determine the applicability of specific scope concepts to target products or methods. These charts are valuable for identifying areas where claim coverage is lacking and for highlighting future design opportunities[3].

Patent Classification and Search Strategies

Patent Classification Systems

Patent classification systems, such as those used by the USPTO and international patent offices, organize patent documents into specific technology groupings. Using these classification systems can streamline the search process and ensure highly relevant results. For instance, searching under the appropriate Cooperative Patent Classification (CPC) or International Patent Classification (IPC) can help in identifying similar patents and technologies[4].

Advanced Search Tools

Advanced search tools like the Patent Public Search tool by the USPTO or databases provided by the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO) offer powerful capabilities for searching and analyzing patent data. These tools can help in conducting thorough searches to ensure that all relevant prior art is considered[1][4].

Conclusion

United States Patent 5,919,775 is a critical component of Galderma's intellectual property portfolio, particularly in the context of treating acne rosacea. Understanding the scope and claims of this patent, as well as its place within the broader patent landscape, is essential for both legal and strategic purposes. By leveraging patent analytics tools and advanced search strategies, companies can better manage their intellectual property assets and identify opportunities for innovation.

Key Takeaways

  • Dependent Claims Matter: Dependent claims can add significant value and specificity to a patent, and their validity should be carefully assessed.
  • Global Patent Family: Understanding the global patent family is crucial for identifying the full scope of protection and potential gaps.
  • Patent Analytics: Tools like Claim Coverage Matrix and interactive claim charts are invaluable for managing and optimizing patent portfolios.
  • Advanced Search Tools: Utilizing advanced search tools and classification systems can streamline the patent search process and ensure comprehensive results.
  • Legal Disputes: Careful examination of all claims, especially dependent ones, is essential in legal disputes involving patent validity.

FAQs

What is the main invention described in U.S. Patent 5,919,775?

The main invention described in U.S. Patent 5,919,775 is a method for treating acne rosacea using a specific formulation of doxycycline that minimizes its antimicrobial activity while retaining its anti-inflammatory properties.

Why are dependent claims important in patent validity assessments?

Dependent claims are important because they add additional limitations or features to the independent claims, which can provide further specificity and protection. Ignoring these claims can lead to incorrect validity assessments, as seen in the case involving Mylan Pharmaceuticals Inc.

How can patent analytics tools help in managing intellectual property assets?

Patent analytics tools, such as Claim Coverage Matrix and interactive claim charts, help in categorizing patents by claims and scope concepts, identifying gaps in coverage, and highlighting future design opportunities. This makes it easier to manage and optimize large patent portfolios.

What are the benefits of using advanced search tools for patent searches?

Advanced search tools, such as the Patent Public Search tool by the USPTO or databases provided by the EPO and WIPO, offer powerful capabilities for searching and analyzing patent data. These tools can help in conducting thorough searches to ensure that all relevant prior art is considered, making the search process more efficient and comprehensive.

How does the Global Dossier help in understanding the patent landscape?

The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application, including related applications, dossier, classification, and citation data. This helps in identifying the broader international protection and any potential gaps or opportunities.

Sources

  1. USPTO: "Search for patents - USPTO" - https://www.uspto.gov/patents/search
  2. JDSupra: "Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc." - https://www.jdsupra.com/legalnews/research-foundation-of-state-university-55072/
  3. SLWIP: "Patent Analytics | Intellectual Property Law" - https://www.slwip.com/services/patent-analytics/
  4. Brown University Library Guides: "Home - Patents - Library Guides at Brown University" - https://libguides.brown.edu/patent
  5. United States Court of Appeals for the Federal Circuit: "Opinion" - https://cafc.uscourts.gov/opinions-orders/12-1523.opinion.8-2-2013.1.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,919,775

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,919,775

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 4080897 ⤷  Subscribe
Australia 718234 ⤷  Subscribe
Canada 2264552 ⤷  Subscribe
Canada 2670296 ⤷  Subscribe
European Patent Office 0966525 ⤷  Subscribe
Japan 2002513386 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.